Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract

Comperat, 2008, Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer, Urology, 72, 873, 10.1016/j.urology.2007.12.026

Comperat, 2007, Aurora-A/STK-15 is a predictive factor for recurrent behavior in noninvasive bladder carcinoma: A study of 128 cases of noninvasive neoplasms, Virchows Arch, 450, 419, 10.1007/s00428-007-0383-x

Frank, 2004, Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement, Cancer, 101, 1803, 10.1002/cncr.20567

Catto, 2003, Distinct patterns of microsatellite instability are seen in tumors of the urinary tract, Oncogene, 22, 8699, 10.1038/sj.onc.1206964

Roupret, 2004, Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma, J Med Genet, 41, e91, 10.1136/jmg.2003.017871

Vogelstein, 1992, p53 Function and dysfunction, Cell, 70, 523, 10.1016/0092-8674(92)90421-8

Bartek, 1991, Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies, Oncogene, 6, 1699

Brown, 2002, Ki67 protein: The immaculate deception?, Histopathology, 40, 2, 10.1046/j.1365-2559.2002.01343.x

Kamijima, 2005, The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter, Int J Urol, 12, 941, 10.1111/j.1442-2042.2005.01159.x

Fromont, 2005, Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin, and MSH2 expression in upper urinary tract transitional cell carcinoma, Eur Urol, 48, 764, 10.1016/j.eururo.2005.07.005

Habuchi, 2005, Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers, Urology, 66, 64, 10.1016/j.urology.2005.08.065

Bischoff, 1999, The Aurora/Ipl1p kinase family: Regulators of chromosome segregation and cytokinesis, Trends Cell Biol, 9, 454, 10.1016/S0962-8924(99)01658-X

Ducat, 2004, Aurora kinases in spindle assembly and chromosome segregation, Exp Cell Res, 301, 60, 10.1016/j.yexcr.2004.08.016

Kawamura, 2003, Centrosome hyperamplification and chromosomal instability in bladder cancer, Eur Urol, 43, 505, 10.1016/S0302-2838(03)00056-3

Fraizer, 2004, Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells, Int J Oncol, 25, 1631

Sen, 2002, Amplification/overexpression of a mitotic kinase gene in human bladder cancer, J Natl Cancer Inst, 94, 1320, 10.1093/jnci/94.17.1320

Mhawech-Fauceglia, 2006, Raf1, Aurora-A/STK15 and E-cadherin biomarkers expression in patients with pTa/pT1 urothelial bladder carcinoma: A retrospective TMA study of 246 patients with long-term follow-up, Eur J Surg Oncol, 32, 439, 10.1016/j.ejso.2006.01.018

Gerdes, 1992, Immunohistologic detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues, J Pathol, 168, 85, 10.1002/path.1711680114

Vojtesek, 1992, An immunochemical analysis of the human nuclear phosphoprotein p53, J Immunol Methods, 151, 237, 10.1016/0022-1759(92)90122-A

Hall, 1998, Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients, Urology, 52, 594, 10.1016/S0090-4295(98)00295-7

Jemal, 2009, Cancer statistics, 2009, CA Cancer J Clin, 59, 225, 10.3322/caac.20006

McCredie, 1983, Analgesics and tobacco as risk factors for cancer of the ureter and renal pelvis, J Urol, 130, 28, 10.1016/S0022-5347(17)50936-2

Lin, 2008, Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth, Clin Cancer Res, 14, 5437, 10.1158/1078-0432.CCR-07-4922

Munoz, 2000, Upper tract urothelial neoplasms: Incidence and survival during the last 2 decades, J Urol, 164, 1523, 10.1016/S0022-5347(05)67019-X

Park, 2004, The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract, J Urol, 171, 621, 10.1097/01.ju.0000107767.56680.f7

Catto, 2007, Behavior of urothelial carcinoma with respect to anatomical location, J Urol, 177, 1715, 10.1016/j.juro.2007.01.030

Lehmann, 2007, Transitional cell carcinoma of the ureter: Prognostic factors influencing progression and survival, Eur Urol, 51, 1281, 10.1016/j.eururo.2006.11.021

Zigeuner, 2004, Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma, Urology, 63, 1079, 10.1016/j.urology.2004.01.009

Kamai, 2000, Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter, BJU Int, 86, 14, 10.1046/j.1464-410x.2000.00726.x

Hong, 2005, Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract, Urology, 65, 692, 10.1016/j.urology.2004.11.001

Saito, 2007, Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically, J Urol, 178, 2291, 10.1016/j.juro.2007.08.019